Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 21, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Awards $300,000 in Grants to Further Research in Preterm Birth and Neonatal Health

WALTHAM, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- As part of the company’s ongoing support of maternal and neonatal health, AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it has awarded...
December 20, 2017 16:01 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Dec. 20, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, president and chief executive officer, will present at the 36th Annual...
December 20, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

New Patent Issued to AMAG Pharmaceuticals Entitled "Methods of Reducing Risk of Preterm Birth"

WALTHAM, Mass., Dec. 20, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the issuance of U.S. Patent Number 9,844,558 entitled “Methods of Reducing Risk of Preterm...
November 08, 2017 16:01 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Present at Upcoming Investor Conference

WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that management will participate in the Jefferies 2017 London Healthcare Conference on...
November 08, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Announces Autologous Cord Blood Cells Improve Motor Function in Some Children with Cerebral Palsy

WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cord Blood Registry (CBR) from AMAG Pharmaceuticals (Nasdaq:AMAG) today announced research recently published in the journal Stem Cells...
November 06, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

Hypophosphatemia Data From AMAG Phase 3 Trial Presented at the American Society of Nephrology

Data Shows Patients Treated with Feraheme® (ferumoxytol) were Less Likely to Develop Severe Hypophosphatemia Compared to Those Treated with a Comparator IV Iron WALTHAM, Mass., Nov. 06, 2017 (GLOBE...
November 02, 2017 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Highlights

Intrarosa® (prasterone) launch progressing well with nearly 2,000 prescribing physicians in the first 100 days since launch Conference call scheduled for 8:00 a.m. ET today WALTHAM, Mass., Nov. 02,...
October 19, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Host Third Quarter 2017 Financial Results Conference Call and Webcast on Thursday, November 2, 2017 at 8:00 a.m. ET

WALTHAM, Mass., Oct. 19, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that its third quarter 2017 financial results will be released on Thursday, November 2,...
September 29, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Appoints Tracy Palmer Berns as Chief Compliance Officer

WALTHAM, Mass., Sept. 29, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Tracy Palmer Berns as chief compliance officer effective immediately....
September 07, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Appoints Laura Williams, M.D. as Senior Vice President of Clinical Development

WALTHAM, Mass., Sept. 07, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Laura Williams, M.D., M.P.H., as senior vice president of clinical...